Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Comparison of pregabalin with pramipexole for restless legs syndrome.

Allen RP, Chen C, Garcia-Borreguero D, Polo O, DuBrava S, Miceli J, Knapp L, Winkelman JW.

N Engl J Med. 2014 Feb 13;370(7):621-31. doi: 10.1056/NEJMoa1303646.

2.

Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.

Garcia-Borreguero D, Patrick J, DuBrava S, Becker PM, Lankford A, Chen C, Miceli J, Knapp L, Allen RP.

Sleep. 2014 Apr 1;37(4):635-43. doi: 10.5665/sleep.3558.

3.

Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.

Ma JF, Wan Q, Hu XY, Sun SG, Wang WZ, Zhao ZX, Wang YJ, Liu CF, Li JM, Jiang YP, Chen SD.

Sleep Med. 2012 Jan;13(1):58-63. doi: 10.1016/j.sleep.2011.03.021.

PMID:
22137119
4.

Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.

Ferini-Strambi L, Aarskog D, Partinen M, Chaudhuri KR, Sohr M, Verri D, Albrecht S.

Sleep Med. 2008 Dec;9(8):874-81. doi: 10.1016/j.sleep.2008.09.001.

PMID:
18952497
5.

Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.

Inoue Y, Hirata K, Kuroda K, Fujita M, Shimizu T, Emura N, Uchimura N, Kagimura T, Sha K, Nozawa T.

Sleep Med. 2010 Jan;11(1):11-6. doi: 10.1016/j.sleep.2009.03.009.

PMID:
19962941
6.

Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.

Garcia-Borreguero D, Larrosa O, Williams AM, Albares J, Pascual M, Palacios JC, Fernandez C.

Neurology. 2010 Jun 8;74(23):1897-904. doi: 10.1212/WNL.0b013e3181e1ce73.

PMID:
20427750
7.

Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.

Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.

Sleep Med. 2006 Aug;7(5):407-17.

PMID:
16815748
8.

Long-term open-label study of pramipexole in patients with primary restless legs syndrome.

Inoue Y, Kuroda K, Hirata K, Uchimura N, Kagimura T, Shimizu T.

J Neurol Sci. 2010 Jul 15;294(1-2):62-6. doi: 10.1016/j.jns.2010.04.003.

PMID:
20451927
9.

Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).

Oertel WH, Stiasny-Kolster K, Bergtholdt B, Hallström Y, Albo J, Leissner L, Schindler T, Koester J, Reess J; Pramipexole RLS Study Group..

Mov Disord. 2007 Jan 15;22(2):213-9.

PMID:
17133582
10.

A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome.

Allen R, Chen C, Soaita A, Wohlberg C, Knapp L, Peterson BT, García-Borreguero D, Miceli J.

Sleep Med. 2010 Jun;11(6):512-9. doi: 10.1016/j.sleep.2010.03.003.

PMID:
20466589
11.

Pramipexole: in restless legs syndrome.

McCormack PL, Siddiqui MA.

CNS Drugs. 2007;21(5):429-37; discussion 438-40. Review.

PMID:
17447832
13.

Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin.

Lee CS, Lee SD, Kang SH, Park HY, Yoon IY.

Eur J Neurol. 2014 Feb;21(2):260-6. doi: 10.1111/ene.12286.

PMID:
24267148
14.

A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.

Sun Y, van Valkenhoef G, Morel T.

Curr Med Res Opin. 2014 Nov;30(11):2267-78. doi: 10.1185/03007995.2014.946124.

PMID:
25050588
15.

Pramipexole for Chinese people with primary restless legs syndrome: a 12-week multicenter, randomized, double-blind study.

Zhang J, Liu B, Zheng Y, Chu T, Yang Z.

Sleep Med. 2015 Jan;16(1):181-5. doi: 10.1016/j.sleep.2014.09.015.

PMID:
25533540
16.

A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.

Jama L, Hirvonen K, Partinen M, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.

Sleep Med. 2009 Jun;10(6):630-6. doi: 10.1016/j.sleep.2008.05.014.

PMID:
19171500
17.

Efficacy and safety of pramipexole in restless legs syndrome.

Winkelman JW, Sethi KD, Kushida CA, Becker PM, Koester J, Cappola JJ, Reess J.

Neurology. 2006 Sep 26;67(6):1034-9.

PMID:
16931507
18.

Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study).

Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.

Sleep Med. 2008 Jul;9(5):537-41. doi: 10.1016/j.sleep.2007.12.004.

PMID:
18276187
19.

Long-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients.

Inoue Y, Uchimura N, Kuroda K, Hirata K, Hattori N.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):251-7. doi: 10.1016/j.pnpbp.2011.10.009.

PMID:
22036917
20.

Dopamine agonists for restless legs syndrome.

Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD006009. doi: 10.1002/14651858.CD006009.pub2. Review.

PMID:
21412893
Items per page

Supplemental Content

Support Center